Barclays PLC Aslan Pharmaceuticals LTD Transaction History

Barclays PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.36 - $24.24 $57,603 - $3.88 Million	-160,009 Reduced 33.95%	311,261 $112,000
Q3 2022 Nov 03, 2022	SELL	$0.42 - $24.68 $15,831 - $930,287	-37,694 Reduced 7.41%	471,270 $283,000
Q4 2021 Feb 14, 2022	BUY	$1.11 - $1.86 $355,422 - $595,572	320,200 Added 169.63%	508,964 $570,000
Q3 2021 Nov 09, 2021	BUY	$1.78 - $3.41 $107,668 - $206,264	60,488 Added 47.15%	188,764 $336,000
Q2 2021 Aug 13, 2021	SELL	$2.5 - $3.72 $775 - $1,153	-310 Reduced 0.24%	128,276 $423,000
Q1 2021 May 13, 2021	BUY	$1.86 - $5.25 $239,169 - $675,076	128,586 New	128,586 $431,000
Q2 2020 Aug 12, 2020	SELL	$0.96 - $2.19 $187 - $427	-195 Closed	0 $0
Q1 2020 May 13, 2020	SELL	$0.93 - $2.8 $93 - $280	-100 Reduced 33.9%	195 $0
Q4 2019 Feb 10, 2020	BUY	$0.37 - $5.2 $109 - $1,534	295 New	295 $1,000

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.